A bill to ensure continued access to diabetes technology upon Medicare enrollment, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4037 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4037 To ensure continued access to diabetes technology upon Medicare enrollment, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 10, 2026 Mrs. Shaheen (for herself and Ms. Collins) introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To ensure continued access to diabetes technology upon Medicare enrollment, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act'' or the ``Diabetes Act''. SEC. 2. FINDINGS; SENSE OF CONGRESS. (a) Findings.--Congress finds the following: (1) According to the Centers for Disease Control and Prevention, in 2021, an estimated 38,400,000 Americans, or 11.6 percent of the entire United States population, have diabetes. (2) The total number of individuals with diabetes is projected to increase to an estimated 54,900,000 individuals by 2030. (3) Diabetes disproportionately impacts the Medicare population, as the Centers for Medicare & Medicaid Services found in 2022, and 26 percent of Medicare beneficiaries have diabetes. (4) Both type 1 and 2 diabetes can significantly harm long- term health and is associated with numerous comorbidities such as cancer, heart disease, chronic kidney disease, blindness, and amputations. (5) The direct and indirect cost of diabetes is significant as the American Diabetes Association found that the total annual cost of diabetes in 2022 was $412,900,000,000, $306,600,000,000 of which is attributable to direct medical c